Specify a stock or a cryptocurrency in the search bar to get a summary
Getinge AB ser. B
GETI-BGetinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, mechanical circulatory support, advanced patient monitoring, ICU infrastructure equipment, patient flow management, and drainage solutions. The company also provides surgical perfusion, endoscopic vessel harvesting, intra-aortic balloon counterpulsation, and drainage solutions; and operating room infrastructure equipment, anesthesia, advanced patient monitoring, operating room management, and operating room integration solutions. In addition, it offers pre-cleaning, cleaning and disinfection, sterilization, consumables, endoscope reprocessing, and sterile supply management solutions; connected medical devices; bioreactor systems, DPTE systems, Getinge isolators, terminal sterilization products, and sterilizers; and vivarium, biohazardous materials handling solutions, labware cleaning and sterilization, upstream bioprocessing, and bioreactor preparation solutions. It offers its products through a network of sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia and Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden. Address: Lindholmspiren 7A, Gothenburg, Sweden, 417 56
Analytics
WallStreet Target Price
2 475.06 SEKP/E ratio
28.9727Dividend Yield
2.46 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures GETI-B
Dividend Analytics GETI-B
Dividend growth over 5 years
183 %Continuous growth
2 yearsPayout Ratio 5 years average
35 %Dividend History GETI-B
Stock Valuation GETI-B
Financials GETI-B
Results | 2019 | Dynamics |